CJC-1295 No DAC (Mod GRF 1-29)
Short-acting GHRH analog studied for pulsatile growth-hormone release.
WHAT IS IT?
CJC-1295 without DAC is a shortened growth-hormone-releasing signal designed to mimic the body's natural, pulsing hormone release.
WHY ARE PEOPLE INTERESTED?
It's studied in performance research — short, natural-style bursts of growth hormone from the pituitary.
WHAT HAS RESEARCH SHOWN?
Animal studies showed rapid hormone release within 15–30 minutes. Human benefit is unproven.
Distinguishes established clinical findings from early human trials, animal experiments, or laboratory cell culture findings. No human dosing, injection instructions, or treatment recommendations are provided.
FDA STATUS
CJC-1295 No DAC is an investigational peptide. It is not FDA-approved for medical therapy.
BBOHC LABS research reagents are non-clinical materials. An FDA approval for a finished medicine containing the same active ingredient does not imply that BBOHC's investigational research vial is FDA-approved.
Known risks & handling
Headache and mild temporary blood-pressure dip on infusion in animals.
Supporting references
- Jetté L et al. Human growth hormone-releasing factor conjugates. Endocrinology. 2005.
Specific citations are provided for literature context. Product purity & lot verification documentation available on request.
Research use only
This material is not intended for human, veterinary, or consumer use and is not represented as a drug, supplement, or therapeutic product. No pricing, add-to-cart, or checkout is available. All requests are reviewed manually by a BBOHC representative; submission of an inquiry is not an accepted order.
Request this materialSpecification sheet
Draft — pending verification
- Molecular weight
- 3367.97 g/mol
- CAS number
- 863288-34-0
- Molecular formula
- C₁₅₂H₂₅₂N₄₄O₄₂
- Package size
- 2 mg / 5 mg (research grade)
- Lot number
- LOT-BBOHC-NODAC-2026Apending
- Verified purity
- Specification pending — analytical CoA available on requestpending
- Appearance
- Lyophilized white powder.pending
Available documents
- Certificate of Analysis (draft)
- Safety Data Sheet (SDS)
Lot traceability
CoA on request
Request this material
All material requests are reviewed manually. No automatic approval, checkout, or fulfillment.
REQUEST MATERIALS (CJC-1295 No DAC (Mod GRF 1-29))Related materials
CJC-1295 / Ipamorelin Blend
Dual growth-hormone secretagogue blend studied for pituitary GH pulse signaling.
Blend (863288-34-0 + 170851-70-4)
CJC-1295 with DAC
Albumin-binding GHRH analog studied for sustained growth-hormone elevation.
863288-34-0 (with DAC adduct)
Ipamorelin
Selective ghrelin-receptor agonist studied for clean growth-hormone release.
170851-70-4